Article
CMS-dependent prognostic impact of KRAS and BRAFV600E mutations in primary colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology - 1 May 2018
Smeby J, Sveen A, Merok M A, Danielsen S A, Eilertsen I A, Guren M G, Dienstmann R, Nesbakken A, Lothe R A
Abstract excerpt
Background: The prognostic impact of KRAS and BRAFV600E mutations in primary colorectal cancer (CRC) varies with microsatellite instability (MSI) status. The gene expression-based consensus molecular subtypes (CMSs) of CRC define molecularly and clinically distinct subgroups, and represent a novel stratification framework in biomarker analysis. We investigated the prognostic value of these mutations within the...
Topics
- Adult
- Aged
- Aged, 80 and over
- Biomarkers, Tumor
- Cohort Studies
- Colorectal Neoplasms
- DNA Mutational Analysis
- Datasets as Topic
- Disease-Free Survival
- Female
